[Double inhalation test with ipratropium bromide and salbutamol--assessment of its effects on partial and maximum expiratory flow-volume curves].
Kamio
Y
Y
Shibayama
M
M
Kawai
K
K
Futamata
H
H
Matsubara
F
F
Kanamori
K
K
Uotani
K
K
Okafuji
K
K
Fujimura
M
M
Koshino
T
T
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000328:Adult; D000420:Albuterol / Q000494:pharmacology*; D001286:Atropine Derivatives / Q000494:pharmacology*; D004341:Drug Evaluation / Q000379:methods; D005260:Female; D005540:Forced Expiratory Flow Rates; D006801:Humans; D009241:Ipratropium / Q000494:pharmacology*; D008449:Maximal Expiratory Flow-Volume Curves; D010276:Parasympatholytics / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D001286:Atropine Derivatives; D010276:Parasympatholytics; D009241:Ipratropium; D000420:Albuterol